Skip to contentSkip to filters

We use cookies for analytics.

Topic: Harmaline

ePoster
3 ePosters

In Neuroscience

ePoster · Neuroscience

Ayahuasca prevents the expression of cocaine-induced conditioned place preference in C57BL/6 mice

Tania Marcourakis, Vitor Bruno, Lidia Spelta, Fabiane Dorr, Beatriz Paranhos, Fabiana Santos, Raphael Garcia, Larissa Torres, Maurício Yonamine, Roberto De Pasquale, Rosana Camarini · FENS Forum 2024

Aims: Evaluate the effects of ayahuasca (AYA) on cocaine (COC)-induced conditioned place preference (CPP). Methods: (A) AYA was lyophilized, and its components were quantified by LC-MS/MS. (B) Six-week-old C57Bl/6 mice were habituated to the CPP apparatus for 15 minutes. The following day, they underwent a pre-test to assess their natural compartmental preference (15 minutes). During the conditioning phase (CT; 3rd-10th day), mice remained confined in one of the CPP compartments for 30 minutes. On the 11th day, they were tested to evaluate: (B.i) Effects of AYA on CPP: on odd CT days, they wer

ePoster · Neuroscience

Disruption of treadmill running by harmaline and cannabinoid agonist in marker-based 3D motion capture of mice

Bogna Ignatowska-Jankowska, Tara Turkki, Lakshmipriya Swaminathan, Marylka Yoe Uusisaari · FENS Forum 2024

In our previous studies, we developed a marker-based 3D motion capture system to evaluate step kinematics during behaviors such as climbing and novel environment exploration under various pharmacological treatments. In the present study, we aimed to test whether the step kinematics of mice is affected during treadmill running at different speeds and under various treatments. We used adult male C57BL/6 mice in a within-subject, randomized design. We recorded voluntary running behavior on a treadmill in mice treated with vehicle (1:1:18 ethanol, Kolliphor, saline), CP55,940 (0.3 mg/kg) or harmal

ePoster · Neuroscience

Disruption of climbing behavior by harmaline in marker-based 3D motion capture of freely moving mice

Tara Turkki, Lakshmipriya Swaminathan, Bogna Ignatowska-Jankowska, Marylka Yoe Uusisaari · FENS Forum 2024

We have developed a marker-based 3D motion capture system for high-precision quantification of mouse locomotion. In our previous studies, we observed that a low dose of a synthetic agonist of cannabinoid CB1 and CB2 receptors, CP55,940 (0.3 mg/kg), causes a small reduction in general locomotion during open-field exploration, but does not inhibit general locomotion during vertical climbing. However, we observed that it induces significant changes in step kinematics during both tasks, which were more pronounced during climbing.We used adult male C57BL/6 mice in a within-subject, randomized desig